龍佰集團(002601.SZ):年產10萬噸鋰離子電池用人造石墨負極材料項目一期建成試生產
格隆匯2月9日丨龍佰集團(002601.SZ)公佈,此前披露,為抓住新能源電池的發展機遇,公司全資子公司河南中炭新材料科技有限公司(“中炭新材料”)擬投資建設年產10萬噸鋰離子電池用人造石墨負極材料項目。
中炭新材料投資建設的年產10萬噸鋰離子電池用人造石墨負極材料項目一期(年產2.5萬噸)生產線已建成,目前進入試生產階段。
該項目未來正式投產後,將有利於公司形成更加完整的產業體系,標誌着公司正式融入新能源材料生產製造供應鏈,為公司實現研發生產新能源電池正負極材料協同發展奠定了基礎;將有利於打造新的利潤增長點,豐富公司產品種類,進一步提高公司抗風險能力和競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.